Cannabinoids and Atherosclerotic Coronary Heart Disease

Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial

(2011) D. H. O'Leary et al.   HEART

Cannabinoid 1 Receptor Blockade Reduces Atherosclerosis with Enhances Reverse Cholesterol Transport

(2011) Koichi Sugamura et al.   Journal of Atherosclerosis and Thrombosis

Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice

(2010) Courtney D. Netherland et al.   ATHEROSCLEROSIS

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function

(2010) Vedat Tiyerili et al.   BASIC RESEARCH IN CARDIOLOGY

Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2

(2010) Courtney Netherland et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors

(2010) Oliver P. Keown et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells

(2010) Mohanraj Rajesh et al.   BRITISH JOURNAL OF PHARMACOLOGY

WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice

(2010) Yan Zhao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules

(2010) Yan Zhao et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Urban Particulate Matter Air Pollution Is Associated With Subclinical Atherosclerosis

(2010) Marcus Bauer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

(2010) Eric J Topol et al.   LANCET

Medical Marijuana and the Law

(2010) Diane E. Hoffmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

(2009) K. H. Han et al.   CARDIOVASCULAR RESEARCH

Cannabidiol-2',6'-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor

(2009) S. Takeda et al.   DRUG METABOLISM AND DISPOSITION

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy

(2009) Nicole Defer et al.   FASEB JOURNAL

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

(2009) Fabrizio Montecucco et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

(Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells

(2009) Effimia Gkoumassi et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

An exploratory prospective study of marijuana use and mortality following acute myocardial infarction

(2008) Kenneth J. Mukamal et al.   AMERICAN HEART JOURNAL

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

(2008) Frédérique Dol-Gleizes et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages

(2008) Kazumi Tsubakio-Yamamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation

(2008) Mohanraj Rajesh et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages

(2008) L.-s. Jiang et al.   CARDIOVASCULAR RESEARCH

Particulate Air Pollution as a Risk Factor for ST-Segment Depression in Patients With Coronary Artery Disease

(2008) Kai Jen Chuang et al.   CIRCULATION

Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages

(2008) Koichi Sugamura et al.   CIRCULATION

Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease

(2008) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CB2cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration

(2007) M Rajesh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

(2007) V E Mendizábal et al.   BRITISH JOURNAL OF PHARMACOLOGY